FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1942136308> ?p ?o ?g. }

• W1942136308 endingPage "2324" @default.
• W1942136308 startingPage "2319" @default.
• W1942136308 abstract "Multikinase inhibitors (MKIs) targeting VEGF receptors and other receptor tyrosine kinases have shown considerable activity in clinical trials of thyroid cancer. Thyroid cancer frequently exhibits activation of the RAS/RAF/MEK/ERK pathway. In other types of cancer, paradoxical ERK activation has emerged as a potential resistance mechanism to RAF-inhibiting drugs including MKIs such as sorafenib and pazopanib. We therefore queried whether the MEK inhibitor trametinib, could augment the activity of pazopanib in thyroid cancer cell lines. Trametinib potently inhibited growth in vitro (GI50 1.1-4.8 nM), whereas pazopanib had more limited in vitro activity, as anticipated (GI50 1.4-7.1 µM). We observed progressive upregulation of ERK activity with pazopanib treatment, an effect abrogated by trametinib. For xenografts (bearing either KRASG12R or BRAFV600E mutations), the combination of trametinib and pazopanib led to sustained shrinkage in tumor volume by 50% or more, compared to pre-treatment baseline. Trametinib also was highly effective as a single agent, compared to pazopanib alone. These preclinical findings support the evaluation of trametinib, alone or in combination with pazopanib or other kinase inhibitors, in thyroid cancer clinical trials. We highlight the importance of pharmacodynamic assessment of the ERK pathway for patients enrolled in trials involving MKIs." @default.
• W1942136308 created "2016-06-24" @default.
• W1942136308 creator A5010169788 @default.
• W1942136308 creator A5032487642 @default.
• W1942136308 creator A5042244536 @default.
• W1942136308 creator A5054686355 @default.
• W1942136308 creator A5057841692 @default.
• W1942136308 creator A5059045910 @default.
• W1942136308 creator A5068048707 @default.
• W1942136308 creator A5071320299 @default.
• W1942136308 creator A5085992065 @default.
• W1942136308 date "2015-08-26" @default.
• W1942136308 modified "2023-10-18" @default.
• W1942136308 title "Trametinib with and without pazopanib has potent preclinical activity in thyroid cancer" @default.
• W1942136308 cites W1989932167 @default.
• W1942136308 cites W2004295816 @default.
• W1942136308 cites W2021960304 @default.
• W1942136308 cites W2037574296 @default.
• W1942136308 cites W2041255253 @default.
• W1942136308 cites W2050206485 @default.
• W1942136308 cites W2051165598 @default.
• W1942136308 cites W2077945404 @default.
• W1942136308 cites W2095771928 @default.
• W1942136308 cites W2099022883 @default.
• W1942136308 cites W2101776780 @default.
• W1942136308 cites W2112967018 @default.
• W1942136308 cites W2113637323 @default.
• W1942136308 cites W2119156172 @default.
• W1942136308 cites W2127515083 @default.
• W1942136308 cites W2133354058 @default.
• W1942136308 cites W2136474966 @default.
• W1942136308 cites W2140765540 @default.
• W1942136308 cites W2141787711 @default.
• W1942136308 cites W2144096834 @default.
• W1942136308 cites W2149662085 @default.
• W1942136308 cites W2154841567 @default.
• W1942136308 cites W2156078931 @default.
• W1942136308 cites W2159234812 @default.
• W1942136308 cites W2162424705 @default.
• W1942136308 cites W2169961966 @default.
• W1942136308 cites W2219978888 @default.
• W1942136308 doi "https://doi.org/10.3892/or.2015.4225" @default.
• W1942136308 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4583528" @default.
• W1942136308 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26324075" @default.
• W1942136308 hasPublicationYear "2015" @default.
• W1942136308 type Work @default.
• W1942136308 sameAs 1942136308 @default.
• W1942136308 citedByCount "14" @default.
• W1942136308 countsByYear W19421363082017 @default.
• W1942136308 countsByYear W19421363082018 @default.
• W1942136308 countsByYear W19421363082019 @default.
• W1942136308 countsByYear W19421363082020 @default.
• W1942136308 countsByYear W19421363082021 @default.
• W1942136308 countsByYear W19421363082022 @default.
• W1942136308 countsByYear W19421363082023 @default.
• W1942136308 crossrefType "journal-article" @default.
• W1942136308 hasAuthorship W1942136308A5010169788 @default.
• W1942136308 hasAuthorship W1942136308A5032487642 @default.
• W1942136308 hasAuthorship W1942136308A5042244536 @default.
• W1942136308 hasAuthorship W1942136308A5054686355 @default.
• W1942136308 hasAuthorship W1942136308A5057841692 @default.
• W1942136308 hasAuthorship W1942136308A5059045910 @default.
• W1942136308 hasAuthorship W1942136308A5068048707 @default.
• W1942136308 hasAuthorship W1942136308A5071320299 @default.
• W1942136308 hasAuthorship W1942136308A5085992065 @default.
• W1942136308 hasBestOaLocation W19421363081 @default.
• W1942136308 hasConcept C121608353 @default.
• W1942136308 hasConcept C126322002 @default.
• W1942136308 hasConcept C143998085 @default.
• W1942136308 hasConcept C184235292 @default.
• W1942136308 hasConcept C2778019345 @default.
• W1942136308 hasConcept C2778439243 @default.
• W1942136308 hasConcept C2778472372 @default.
• W1942136308 hasConcept C2778695046 @default.
• W1942136308 hasConcept C2779490328 @default.
• W1942136308 hasConcept C2779761222 @default.
• W1942136308 hasConcept C2781249067 @default.
• W1942136308 hasConcept C502942594 @default.
• W1942136308 hasConcept C57074206 @default.
• W1942136308 hasConcept C71924100 @default.
• W1942136308 hasConcept C86803240 @default.
• W1942136308 hasConcept C95444343 @default.
• W1942136308 hasConcept C98274493 @default.
• W1942136308 hasConceptScore W1942136308C121608353 @default.
• W1942136308 hasConceptScore W1942136308C126322002 @default.
• W1942136308 hasConceptScore W1942136308C143998085 @default.
• W1942136308 hasConceptScore W1942136308C184235292 @default.
• W1942136308 hasConceptScore W1942136308C2778019345 @default.
• W1942136308 hasConceptScore W1942136308C2778439243 @default.
• W1942136308 hasConceptScore W1942136308C2778472372 @default.
• W1942136308 hasConceptScore W1942136308C2778695046 @default.
• W1942136308 hasConceptScore W1942136308C2779490328 @default.
• W1942136308 hasConceptScore W1942136308C2779761222 @default.
• W1942136308 hasConceptScore W1942136308C2781249067 @default.
• W1942136308 hasConceptScore W1942136308C502942594 @default.
• W1942136308 hasConceptScore W1942136308C57074206 @default.
• W1942136308 hasConceptScore W1942136308C71924100 @default.
• W1942136308 hasConceptScore W1942136308C86803240 @default.

• next